Products

Boom In Naloxone Tied To Fewer Drug Deaths

Health Care August 2019
Naloxone, an overdose-reversing drug, is being tied to fewer drug-related deaths in the U.S. Overdose deaths have stopped rising for the first time in the United States in decades.

Boom In Naloxone Tied To Fewer Drug Deaths

Overdose Deaths Have Stopped Rising For 1st Time In Nearly 3 Decades

By MIKE STOBBE AP Medical Writer

NEW YORK (AP) — Prescriptions of the overdose-reversing drug naloxone are soaring, and experts say that could be a reason overdose deaths have stopped rising for the first time in nearly three decades.

The number of naloxone prescriptions dispensed by U.S. retail pharmacies doubled from 2017 to last year, rising from 271,000 to 557,000, health officials reported Tuesday.

The United States is in the midst of the deadliest drug overdose epidemic in its history. About 68,000 people died of overdoses last year, according to preliminary government statistics reported last month, a drop from the more than 70,000 in 2017.

"One could only hope that this extraordinary increase in prescribing of naloxone is contributing to that stabilization or even decline of the crisis," said Katherine Keyes, a Columbia University drug abuse expert.

About two-thirds of U.S. overdose deaths involve some kind of opioid, a class of drugs that includes heroin, certain prescription painkillers and illicit fentanyl. Naloxone is a medication that can reverse opioid overdoses, restoring breathing and bringing someone back to consciousness. It first went on sale in 1971 as an injection. An easier-to-use nasal spray version, Narcan, was approved in 2015.

Local, state and federal officials have embraced naloxone as a lifesaving measure. Cities and states have standing orders that allow pharmacies to give it out without a doctor's prescription, and officials have tried to put it into the hands of virtually anyone who might encounter a person overdosing, including drug users, police and even librarians.

CDC researchers noted there were fewer than 1,300 naloxone prescriptions dispensed in 2012, meaning the number grew more than 430-fold in six years.

Health officials said pharmacies should be giving out even more.

"We don't think anybody is at the level we'd like to see them," said Dr. Anne Schuchat of the Centers for Disease Control and Prevention.

The CDC report is based on data from IQVIA, a company that tracks health care information, and looked at prescriptions from more than 50,000 retail pharmacies across the country. It included both prescriptions written by doctors for specific patients and those filled under the broader standing orders.

The report offers only a partial picture, however, since only about 20% of naloxone was sold to retail pharmacies in 2017, according to an earlier government report.

Still, it's the CDC's first close look at where most retail dispensing is happening. The agency provided data for about 2,900 of the nation's 3,100 counties and parishes.

The researchers found it was most common in cities, and in the South.

Experts said the findings likely reflect a number of factors. More naloxone is likely prescribed in places where more people are using opioids and where policies increase access.

Of the 30 counties with the highest rate of naloxone dispensing in 2018, 13 were in Virginia and five were in Kentucky. But the highest naloxone dispensing rate was in Marshall County, Indiana, according to the CDC data.

The CDC recommends that naloxone be prescribed to patients who are getting high-dose opioids and are at risk for an overdose. It noted that only one naloxone prescription is written for every 69 high-dose opioid prescriptions.

Another finding: The number of high-dose opioid prescription painkillers dispensed fell to about 38 million last year, from nearly 49 million the year before.

That likely also contributed to the decline in overdose deaths last year, Schuchat said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

___

This story has been corrected to show Virginia had 13 of the highest-dispensing counties, not 11.

In addition to bringing our readers stories about education issues in America, we here at Hispanic Outlook feature news articles on topics both related to and outside of the field of education on our website and in our social media.

Hispanic Outlook is an education magazine in the US available both in print and digital form.  Visit https://www.hispanicoutlook.com/education-magazine for information about our latest issue, including our new supplement Physician Outlook.

Renew your subscription to Hispanic Outlook https://www.hispanicoutlook.com/magazine-online-subscription

Hispanic Outlook’s Job Board allows applicants to search for jobs by category, by city and by state.  Both Featured and Latest Job Positions are available at https://hispanicoutlookjobs.com/ 

And for employers, Hispanic Outlook’s Job Board offers a wide variety of posting options.  Further information is available at https://hispanicoutlookjobs.com/employer-products/

Other articles from Hispanic Outlook:

US Overdose Deaths Appear To Be Falling
Preliminary data from the Centers for Disease Control and Prevention suggests that drug overdose deaths in the United States are falling for the first time in nearly three decades.
NEW YORK (AP) — U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary numbers suggest. The Centers for Disease Control and Prevention on Wednesday posted data showing nearly 68,000 drug overdose deaths were reported last year. The number may go up as more investigations are completed, but the agency expects the tally will end up below 69,000. Overdose deaths had been climbing each year since 1990, topping 70,000 in 2017. The numbers were celebrated by the U.S. secretary of health and human services. "Lives are being saved, and we're beginning to win the fight against this crisis," Alex Azar wrote in a tweet. But the overdose death rate is still about seven times higher than it was a generation ago. "We're still in a pretty sad situation that we need to address," said Rebecca Haffajee, a University of Michigan researcher. Researchers do not…
Read full article here

Marijuana And The Opioid Crisis
Editor’s Note: Contradicting a study from 2014, Stanford researchers have found no connection between medical marijuana availability and the reduction of fatal opioid overdoses.
Legalizing medical marijuana does not reduce the rate of fatal opioid overdoses, according to researchers at the Stanford University School of Medicine. The finding contradicts a 2014 study that legal-pot advocates, public officials and even physicians have touted as a reason to legalize marijuana. That study found lower rates of fatal opioid overdoses in the states that had legalized marijuana for medical purposes than in states where marijuana remained illegal. The Stanford study, which revisited the issue after many more states had legalized medical marijuana, found no evidence of a connection between opioid deaths and the availability of medical cannabis, said Keith Humphreys, Ph.D., professor of psychiatry and behavioral sciences. “If you think opening a bunch of dispensaries is going to reduce opioid deaths, you’ll be disappointed,” Humphreys said. “We don’t…
Read full article here

Adding Insult To Injury
Imagine having a job you love. Imagine it’s a job you spent years preparing for and took on a huge student debt just so you could fulfill your dream of having this particular career. Now imagine that each and every day you live with the stress that one false move, action or misinterpreted word could risk everything you own and your ability to continue to do what you love. That’s the occupational hazard of being a Doctor. Law enforcement professionals and firefighters face jeopardy that is obvious and acknowledged by society—and even honored.  But the Physician is often not viewed with much sympathy. For Patients who are unhappy with their medical treatment for a variety of reasons from the benign (having unreasonable expectations about the progress and extent of recovery) to the malignant (“wrong” diagnosis, medical device failure or pharmaceutical complications…
Read full article here

Share with:

Product information

Post a Job

Post a job in higher education?

Place your job ad in our classified page on the HO print & digital Edition